Streamlining cell and gene therapy supply chains: using semi-automation and AI for cost reduction

Abi Pinchbeck, Editor, Cell & Gene Therapy Insights, speaks to Stephan Kadauke, Associate Professor of Clinical Pathology and Lab Medicine, Children’s Hospital of Philadelphia, exploring the complexities of traditional supply chains in cell and gene therapies (CGTs) and how semi-automated processes could help to simplify them. They also discuss how artificial intelligence (AI) and machine learning could be used to automate and reduce the costs of CAR-T manufacturing.

Please enter your email to access content Read now